Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1436800
This article is part of the Research Topic Efficacy and Mechanism of Herbal Medicines and Their Functional Compounds in Preventing and Treating Cardiovascular Diseases and Cardiovascular Disease Risk Factors - Volume II View all 11 articles

QiShenYiQi pills ameliorate retinal microvascular hyperpermeability in db/db mice through improving mitochondrial function and stabilizing cytoskeleton

Provisionally accepted
Zheng Wang Zheng Wang 1,2An-Qing Li An-Qing Li 1,2Li Yan Li Yan 1,2Chong Yang Chong Yang 1,2Song Guo Song Guo 1,2Chunshui Pan Chunshui Pan 1,2*De-Xin Li De-Xin Li 1,2Yi Zhang Yi Zhang 1,2Jing-Xin Zhang Jing-Xin Zhang 1,2Kai Sun Kai Sun 1,2Xinmei Huo Xinmei Huo 1,2Guibo Sun Guibo Sun 3Lijun Zhong Lijun Zhong 2,4Jing-Yan Han Jing-Yan Han 1,2*Jian Liu Jian Liu 1,2*
  • 1 Academy of integration of Chinese and Western Medicine, Health Science Centre, Peking University, Beijing, Beijing Municipality, China
  • 2 Health Science Centre, Peking University, Beijing, China
  • 3 Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing Municipality, China
  • 4 Center of Medical and Health Analysis, Health Science Centre, Peking University, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

    Objective: Diabetic retinopathy (DR) is a leading cause of blindness in adults worldwide. The present study aims to evaluate whether QiShenYiQi pills (QSYQ), a traditional Chinese medicine, can suppress diabetic retinal microvascular leakage in db/db diabetic mice. Methods: C57BL/6 and db/db mice at the age of 6 (pre-treatment groups) or 8 (post-treatment groups) weeks were orally administered with low (0.25 g/kg), medium (0.50 g/kg), and high (1.00 g/kg) dose of QSYQ until 14 weeks old, respectively. FITC-dextran leakage and fluorescein sodium leakage, retinal morphological changes, retinal microvascular obstruction were evaluated; proteomics were used to find potential targets of QSYQ; the expression of Claudin-5, Occludin, ZO-1, JAM-1, VE-cadherin, ATP5α, ATP5β, ATP5D, VEGFR2, Ndufs3, Ndufb8, Acad9, Septin6, Tubb6, Dnm1, MMP2/9 and reactive oxygen species (ROS) were detected. Results: Both pre- and post-administration of QSYQ could alleviate retinal microvascular leakage in db/db mice. Post-administration with a medium dose of QSYQ could reduce retinal microvascular blockage, suppress the downregulation of endothelial cell junction proteins Occludin and Claudin-5, and suppress the elevated expression of VEGFR2, MMP2/9 and the ROS levels. Proteomics analysis and further validation proved that, QSYQ inhibited the downregulation of cytoskeleton-related proteins Septin6 and Dnm1, and mitochondrial respiratory chain complex I related proteins Ndufs3 and Acad9 in retinal tissue of db/db mice. Conclusions: The present study demonstrated that administration of QSYQ could attenuate retinal microvascular hyperpermeability in db/db mice, providing evidence for the clinical use of QSYQ in preventing retinal microvascular leakage in diabetic patients.

    Keywords: microvascular hyperpermeability, cell junction, Energy Metabolism, Cytoskeleton, QSYQ

    Received: 22 May 2024; Accepted: 07 Jan 2025.

    Copyright: © 2025 Wang, Li, Yan, Yang, Guo, Pan, Li, Zhang, Zhang, Sun, Huo, Sun, Zhong, Han and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Chunshui Pan, Academy of integration of Chinese and Western Medicine, Health Science Centre, Peking University, Beijing, 100191, Beijing Municipality, China
    Jing-Yan Han, Academy of integration of Chinese and Western Medicine, Health Science Centre, Peking University, Beijing, 100191, Beijing Municipality, China
    Jian Liu, Health Science Centre, Peking University, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.